In vitro studies [150] revealed that SSc fibroblasts exhibit greater resistance to Fas-mediated apoptosis and lower ASMase and transforming growth factor beta (TGFβ) expression, with the latter being an important fibrogenic cytokine in SSc. The gene discussed is TGFB1; the disease is systemic sclerosis.